Eventide Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$20.6M Buy
2024
Q1
Sell
2023
Q4
$16.4M Hold
2023
Q3
$20.4M Hold
2023
Q2
$24.1M Buy
2023
Q1
$13.4M Buy
2022
Q4
$9.24M Buy